The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality.
Urology
; 119: 70-78, 2018 Sep.
Article
in En
| MEDLINE
| ID: mdl-29906480
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Prostatic Hyperplasia
/
Adrenergic alpha-Antagonists
/
5-alpha Reductase Inhibitors
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Urology
Year:
2018
Type:
Article